HudsonAlpha Researchers Recognize Biomarkers and Potential Treatments for Ovarian Cancer
Despite significant gains made in cancer diagnosis and treatment over the last 50 years, ovarian cancer remains the second most common, as well as the deadliest, of all gynecological cancers in the United States. Ranking fifth in cancer deaths among women, it accounts for more deaths than any other cancer of the female reproductive system. […]